GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bristol-Myers Squibb Co (LIM:BMY) » Definitions » Receivables Turnover

Bristol-Myers Squibb Co (LIM:BMY) Receivables Turnover : 1.34 (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Bristol-Myers Squibb Co Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Bristol-Myers Squibb Co's Revenue for the three months ended in Mar. 2024 was $11,865 Mil. Bristol-Myers Squibb Co's average Accounts Receivable for the three months ended in Mar. 2024 was $8,854 Mil. Hence, Bristol-Myers Squibb Co's Receivables Turnover for the three months ended in Mar. 2024 was 1.34.


Bristol-Myers Squibb Co Receivables Turnover Historical Data

The historical data trend for Bristol-Myers Squibb Co's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bristol-Myers Squibb Co Receivables Turnover Chart

Bristol-Myers Squibb Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Receivables Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.71 6.21 6.10 5.72 5.28

Bristol-Myers Squibb Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.42 1.41 1.33 1.33 1.34

Competitive Comparison of Bristol-Myers Squibb Co's Receivables Turnover

For the Drug Manufacturers - General subindustry, Bristol-Myers Squibb Co's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bristol-Myers Squibb Co's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bristol-Myers Squibb Co's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Bristol-Myers Squibb Co's Receivables Turnover falls into.



Bristol-Myers Squibb Co Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Bristol-Myers Squibb Co's Receivables Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Receivables Turnover (A: Dec. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Dec. 2023 ) / ((Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count )
=45006 / ((8151 + 8882) / 2 )
=45006 / 8516.5
=5.28

Bristol-Myers Squibb Co's Receivables Turnover for the quarter that ended in Mar. 2024 is calculated as

Receivables Turnover (Q: Mar. 2024 )
=Revenue / Average Total Inventories
=Revenue (Q: Mar. 2024 ) / ((Accounts Receivable (Q: Dec. 2023 ) + Accounts Receivable (Q: Mar. 2024 )) / count )
=11865 / ((8882 + 8826) / 2 )
=11865 / 8854
=1.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Bristol-Myers Squibb Co  (LIM:BMY) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


Bristol-Myers Squibb Co Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Bristol-Myers Squibb Co's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Bristol-Myers Squibb Co (LIM:BMY) Business Description

Address
430 East 29th Street, 14th Floor, New York, NY, USA, 10016
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.